GoodRx Announces New Way for Consumers to Access Sanofi's Lantus for $35 at Over 70,000 Pharmacies NationwideBusiness Wire • 10/19/23
Press Release: Sanofi delivers first medicines from Global Health Unit's Impact brand portfolioGlobeNewsWire • 10/19/23
Press Release: TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The NEJMGlobeNewsWire • 10/18/23
Press Release: Late-breaking amlitelimab Phase 2b data presented at EADV show potential best-in-class profile in atopic dermatitisGlobeNewsWire • 10/13/23
BioMap Establishes a Strategic Collaboration with Sanofi to Co-Develop AI Modules to Accelerate Drug Discovery for BiotherapeuticsBusiness Wire • 10/10/23
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.Investors Business Daily • 10/04/23
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease TreatmentBusiness Wire • 10/04/23
Press Release: Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatmentGlobeNewsWire • 10/04/23
Press Release - Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatmentGlobeNewsWire • 10/04/23
Sanofi and Janssen join forces to develop E.coli vaccine, with Sanofi's $175M upfront paymentFox Business • 10/03/23
The US Stock Market Could Crack in October: 6 ‘Strong Buy' European Dividend Aristocrats to Buy Now24/7 Wall Street • 09/29/23
Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority ReviewGlobeNewsWire • 09/26/23
Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia AGlobeNewsWire • 09/25/23